CareMax (CMAX)
(Delayed Data from NSDQ)
$1.70 USD
-0.18 (-9.57%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.71 +0.01 (0.59%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
CMAX 1.70 -0.18(-9.57%)
Will CMAX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CMAX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CMAX
CareMax, Inc. (CMAX) Reports Q2 Loss, Misses Revenue Estimates
Outbrain Inc. (OB) Reports Break-Even Earnings for Q2
CMAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Duolingo (DUOL) to Report Q1 Earnings: What's in the Cards?
Marathon Digital (MARA) to Post Q1 Earnings: What's in Store?
Will Top-Line Improvement Aid Arm Holdings' (ARM) Q1 Earnings?
Other News for CMAX
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Truist Financial Sticks to Its Hold Rating for CareMax (CMAX)
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
CareMax GAAP EPS of -$44.70, revenue of $198.6M
CareMax Reports Second Quarter 2024 Results